• Profile

Prospective assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its clinical impact on the management of high-risk non–muscle-invasive bladder cancer patients candidate for repeated transurethral resection

European Urology Nov 13, 2019

Del Giudice F, Barchetti G, De Berardinis E, et al. - In this study, experts prospectively verified Vesical Imaging Reporting and Data System (VI-RADS) for distinguishing between non-muscle-invasive bladder cancer (MIBC) and MIBC at transurethral resection of bladder tumor (TURBT) and assessed the exactitude of VI-RADS for recognizing high risk (HR)-NMIBC cases who could circumvent repeated (Re)-TURBT and identifying those at greater risk for understaging following TURBT. A total of 231 persons were recruited. For distinguishing between NMIBC and MIBC, VI-RADS was found out to be accurate. Thus, within HR-NMIBC cases, VI-RADS could enhance the choice of individuals who are eligible for Re-TURBT in the future.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen